Status:
UNKNOWN
Terlipressin Administration in Septic Shock Refractory to Catecholamines
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Septic Shock
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
terlipressin is given to refractory septic shock patients who do not respond to noradrenalin in Israel and Europe. It is given by bolus injection. we attempt to investigate weather it is better to giv...
Eligibility Criteria
Inclusion
- septic shock patients receiving above 0.5 mcg/kg NA
Exclusion
- allergy to terlipressin, CHF, IHD, pregnancy
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00793559
Start Date
November 1 2008
End Date
July 1 2009
Last Update
November 19 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asaf Harofeh MC
Zrifin, Israel, 70300